期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

门静脉取栓结扎联合微波消融肝实质分隔二步肝切除术治疗原发性肝癌合并门静脉主干癌栓 被引量：8

原文传递
导出
摘要 手术切除是治疗肝癌的主要方法,足够的剩余肝脏体积（future liver remnant volume,FLR）是肝癌根治性切除的必要条件.很多大肝癌和多发性肝癌患者因FLR不足而失去了手术机会.对FLR不足的肝癌患者可采用门静脉栓塞、门静脉结扎、肝脏离断等方法促进肝脏再生,FLR达到安全切除范围后再行肝癌切除术.我们对1例FLR不足的原发性肝癌合并门静脉主干癌栓患者成功施行了门静脉取栓结扎联合微波消融肝实质分隔的二步肝切除术,治疗效果满意,现报告如下.
作者 卢毅 张成武 刘杰 姚伟锋 洪德飞 胡智明 黄东胜
机构地区 浙江省人民医院肝胆胰外科
出处 《中华外科杂志》 CAS CSCD 北大核心 2017年第4期308-310,共3页 Chinese Journal of Surgery
关键词 门静脉主干癌栓 原发性肝癌 二步肝切除术 静脉结扎 治疗效果 微波消融 静脉取栓 肝实质
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献78

  • 1Masami Minagawa,Masatoshi Makuuchi.Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus[J].World Journal of Gastroenterology,2006,12(47):7561-7567. 被引量：78
  • 2Alexander J. Thompson,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric J. Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg W. Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem H. Ghalib,Bradley Freilich,Lisa M. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David B. Goldstein,John G. McHutchison.Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus[J]. Gastroenterology . 2010 (1)
  • 3Josep M. Llovet,Jordi Bruix.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology . 2003 (2)
  • 4Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
  • 5Shukui Qin,Yuxian Bai,Ho Yeong Lim,Sumitra Thongprasert,Yee Chao,Jia Fan,Tsai-Shen Yang,Vajarabhongsa Bhudhisawasdi,Won Ki Kang,Yu Zhou,Jee Hyun Lee,Yan Sun.Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia[J].Journal of Clinical Oncology.2013(28)
  • 6Stephen L. Chan,Frankie K. F. Mo,Cesar S. C. Wong,Charles M. L. Chan,Linda K. S. Leung,Edwin P. Hui,Brigette B. Ma,Anthony T. C. Chan,Tony S. K. Mok,Winnie Yeo.A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma[J].Cancer.2011(16)
  • 7Josep Llovet,Concepció Brú,Jordi Bruix.Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification[J].Semin Liver Dis.1999(03)
  • 8Sang Min Yoon,Young-Suk Lim,Hyung Jin Won,Jong Hoon Kim,Kang Mo Kim,Han Chu Lee,Young-Hwa Chung,Yung Sang Lee,Sung Gyu Lee,Jin-hong Park,Dong Jin Suh.Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes[J]. International Journal of Radiation Oncology, Biology, Physics . 2012 (5)
  • 9Chai Hong Rim,Dae Sik Yang,Young Je Park,Won Sup Yoon,Jung Ae Lee,Chul Yong Kim.Effectiveness of High-dose Three-dimensional Conformal Radiotherapy in Hepatocellular Carcinoma with Portal Vein Thrombosis. Japanese Journal of Clinical Oncology . 2012
  • 10Daisuke Ban,Kazuaki Shimada,Yusuke Yamamoto,Satoshi Nara,Minoru Esaki,Yoshihiro Sakamoto,Tomoo Kosuge.Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein[J]. Journal of Gastrointestinal Surgery . 2009 (11)

共引文献49

同被引文献61

引证文献8

二级引证文献35

中华外科杂志
2017年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部